Presentation THT 2025 Changes in Seated Pulmonary Artery Pressure in Response to Titration of Heart Failure Medications During Ambulatory Monitoring Presenter: Sandip Zalawadiya February 11, 2025
Presentation THT 2025 Resurgence of Interest in the Role of Inflammation in HF Presenter: Douglas Mann February 11, 2025
Presentation THT 2025 Obesity: Assessing the Weight of the Evidence Presenter: Milton Packer February 11, 2025
Presentation THT 2025 MRAs Redux: New Evidence in Heart Failure Presenter: Scott Solomon February 11, 2025
Presentation THT 2025 Mineralocorticoid Antagonism in Heart Failure: Mechanistic Foundations Presenter: Faiez Zannad February 11, 2025
Presentation THT 2025 Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial Presenter: Gregg W. Stone February 11, 2025
Presentation THT 2025 Winning the War on Shock: Insights From the Premier Database Presenter: Joseph Ibrahim February 11, 2025
Presentation THT 2025 Use of Vericiguat in Durable Left Ventricular Assist Device Patients Presenter: Boaz Elad February 11, 2025
Presentation THT 2025 TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year Presenter: Aasim Afzal February 11, 2025
Presentation THT 2025 Trends and Outcomes of Revascularization in Cardiogenic Shock: A Matched Cohort Analysis Presenter: Joseph Ibrahim February 11, 2025
Presentation THT 2025 Transcatheter Mitral Valve Replacement for Patients With Failed Mitral Valve or Ring Prostheses Presenter: Donald Popke February 11, 2025
Presentation THT 2025 Sex Differences in the Utilization and Outcomes of Advanced MCS Devices in Cardiogenic Shock Presenter: Emily Rodriguez February 11, 2025
Presentation THT 2025 Relationship Between Changes in Pulmonary Artery Pressure, Blood Pressure and Weight in Response to Titration of Heart Failure Medications During Ambulatory Monitoring Presenter: Sandip Zalawadiya February 11, 2025
Presentation THT 2025 Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Subcutaneous (SC) Injection of a Novel-Formulation of Furosemide (FUR) Administered via an Autoinjector Presenter: John Mohr February 11, 2025
Presentation THT 2025 Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy Presenter: Ahmed Mahmoud February 11, 2025
Presentation THT 2025 Mechanical Circulatory Support Within a Large Academic Health System Presenter: Arinze Bosah February 11, 2025
Presentation THT 2025 Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs Presenter: Anthony Carnicelli February 11, 2025
Presentation THT 2025 Impact of Psychological Comorbidities on Clinical Outcomes in Heart Failure With Reduced Ejection Fraction (HFrEF) Presenter: Jonathan Zawadzki February 11, 2025
Presentation THT 2025 Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support Presenter: Abduljabar Adi February 11, 2025
Presentation THT 2025 Impact of Barostim Therapy on Nonsustained Ventricular Tachycardia: A Retrospective Single-Center Study Presenter: Hata Mujadzic February 11, 2025